1993~
Breaking away from a crisis and creating value
Tsumura, which had fallen into a crisis situation, appointed a president from outside the company for the first time in 1995 and started measures to improve its management, including reducing interest-bearing debt and divesting subsidiaries.
Tsumura also worked to restructure the sales organization and promote and establish Kampo medicine. In the fiscal year ended March 31, 2004, Tsumura resumed dividend payments, coming back from the brink.
Since then, Tsumura has taken various measures to promote Kampo medicine, including “ikuyaku” or post-marketing drug rearing to establish scientific evidence for Kampo medicine, creating a crude drug traceability system, expanding Kampo medicine internationally, and establishing Yubari Tsumura and Lao Tsumura.
-
1993
100th anniversary
Tsumura held an International Kampo Symposium to commemorate the 100th anniversary of the company.
-
1999
Kampo medicine seminars started
Kampo medicine seminars (introductory course) started.
-
2001
Shanghai Tsumura Pharmaceuticals Co., Ltd. established
Shanghai Tsumura Pharmaceuticals Co., Ltd. was established as a manufacturing base for extract powder (intermediate products) in China.
-
2004
Promotion of ikuyaku (post-marketing drug rearing)
Tsumura changed the R&D policy to specialize in Kampo and crude drugs and promote ikuyaku (post-marketing drug rearing).
-
2007
Head office relocated
The head office was moved from Nibancho, Chiyoda-ku to Akasaka, Minato-ku.
-
2009
Yubari Tsumura established
A subsidiary, Yubari Tsumura Co., Ltd., was established to oversee the crude drugs business in Hokkaido.
-
2010
Lao Tsumura established
Lao Tsumura Co., Ltd. was established as a base for the cultivation, procurement, preparation and processing, and storage of crude drug ingredients in Laos.
-
2015
Packaging design changed
New bar code labelling was adopted and packaging designs for prescription drugs were changed.
-
2017
Joint venture with Ping An Insurance established in China
Tsumura signed a contract with Ping An Insurance (Group) Company of China, Ltd. to establish a joint venture. Tsumura signed a contract with Tianjin China Medico Technology Co., Ltd. to establish a joint venture.
